标题
Bile Acid Sequestrants: Glucose-Lowering Mechanisms and Efficacy in Type 2 Diabetes
作者
关键词
Bile acid sequestrants, Resins, Type 2 diabetes, Glycemic control, Mechanism of action, Glucose-lowering mechanisms
出版物
Current Diabetes Reports
Volume 14, Issue 5, Pages -
出版商
Springer Nature
发表日期
2014-03-12
DOI
10.1007/s11892-014-0482-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- AACE Comprehensive Diabetes Management Algorithm 2013
- (2015) Alan Garber et al. Endocrine Practice
- Colestilan decreases weight gain by enhanced NEFA incorporation in biliary lipids and fecal lipid excretion
- (2013) Kanami Sugimoto-Kawabata et al. JOURNAL OF LIPID RESEARCH
- The combination of colesevelam with sitagliptin enhances glycemic control in diabetic ZDF rat model
- (2012) Quan Shang et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice
- (2012) Matthew J. Potthoff et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic β cells
- (2012) Divya P. Kumar et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Effect of a Bile Acid Sequestrant on Glucose Metabolism in Subjects With Type 2 Diabetes
- (2012) G. Smushkin et al. DIABETES
- Colesevelam Improves Oral but Not Intravenous Glucose Tolerance by a Mechanism Independent of Insulin Sensitivity and -Cell Function
- (2012) A. L. Marina et al. DIABETES CARE
- Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers
- (2012) T. E. Adrian et al. DIABETOLOGIA
- Hypoglycemic effects of colestimide on type 2 diabetic patients with obesity
- (2012) Tamotsu Neda et al. ENDOCRINE JOURNAL
- The Receptor TGR5 Mediates the Prokinetic Actions of Intestinal Bile Acids and Is Required for Normal Defecation in Mice
- (2012) Farzad Alemi et al. GASTROENTEROLOGY
- Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
- (2012) Geoffrey Porez et al. JOURNAL OF LIPID RESEARCH
- Colestyramine slows gastric emptying of liquids and reduces appetite in healthy subjects
- (2012) A. Psichas et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Bile Acid Binding Resin Improves Metabolic Control through the Induction of Energy Expenditure
- (2012) Mitsuhiro Watanabe et al. PLoS One
- TGR5 potentiates GLP-1 secretion in response to anionic exchange resins
- (2012) Taoufiq Harach et al. Scientific Reports
- Bile acid sequestrants
- (2011) Carolien Out et al. CURRENT OPINION IN LIPIDOLOGY
- Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus
- (2011) R. R. Henry et al. DIABETES OBESITY & METABOLISM
- Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study
- (2011) C. Beysen et al. DIABETOLOGIA
- Bile Acid Sequestration Reduces Plasma Glucose Levels in db/db Mice by Increasing Its Metabolic Clearance Rate
- (2011) Maxi Meissner et al. PLoS One
- Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1
- (2010) Quan Shang et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes
- (2010) Verena Keitel et al. BIOLOGICAL CHEMISTRY
- Effects of colesevelam on LDL-C, A1c and GLP-1 levels in patients with type 1 diabetes: a pilot randomized double-blind trial
- (2010) S. K. Garg et al. DIABETES OBESITY & METABOLISM
- Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism
- (2010) Gemma Brufau et al. HEPATOLOGY
- Bile acid sequestrants improve glycemic control in type 2 diabetes: A proposed mechanism implicating glucagon-like peptide 1 release
- (2010) Alan F. Hofmann HEPATOLOGY
- Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice
- (2010) Galya Vassileva et al. JOURNAL OF ENDOCRINOLOGY
- The Effect of Colesevelam Hydrochloride on Insulin Sensitivity and Secretion in Patients With Type 2 Diabetes: A Pilot Study
- (2010) Sherwyn L. Schwartz et al. Metabolic Syndrome and Related Disorders
- Plasma bile acids are not associated with energy metabolism in humans
- (2010) Gemma Brufau et al. Nutrition & Metabolism
- TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
- (2009) Charles Thomas et al. Cell Metabolism
- Effects of Chenodeoxycholate and a Bile Acid Sequestrant, Colesevelam, on Intestinal Transit and Bowel Function
- (2009) Suwebatu T. Odunsi–Shiyanbade et al. Clinical Gastroenterology and Hepatology
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
- (2009) Kausik K Ray et al. LANCET
- Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
- (2009) Philippe Lefebvre et al. PHYSIOLOGICAL REVIEWS
- Efficacy and Safety of Colesevelam in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Receiving Insulin-Based Therapy
- (2008) Ronald B. Goldberg ARCHIVES OF INTERNAL MEDICINE
- Colesevelam Hydrochloride Therapy in Patients With Type 2 Diabetes Mellitus Treated With Metformin
- (2008) Harold E. Bays et al. ARCHIVES OF INTERNAL MEDICINE
- Expression and function of the bile acid receptor TGR5 in Kupffer cells
- (2008) Verena Keitel et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Gpr40 Is Expressed in Enteroendocrine Cells and Mediates Free Fatty Acid Stimulation of Incretin Secretion
- (2008) S. Edfalk et al. DIABETES
- Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy
- (2008) V. A. Fonseca et al. DIABETES CARE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now